Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

被引：0
作者：
Fardin Dolatimehr
Hamidreza Karimi-Sari
Mohammad Saeid Rezaee-Zavareh
Seyed Moayed Alavian
Bita Behnava
Mohammad Gholami-Fesharaki
Heidar Sharafi
机构：
[1] Student Research Committee,Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL)
[2] Baqiyatallah University of Medical Sciences,Department of Biostatistics, Faculty of Medical Sciences
[3] Meta-analysis Study Group,undefined
[4] Iran Hepatitis Network,undefined
[5] Baqiyatallah University of Medical Sciences,undefined
[6] Middle East Liver Disease (MELD) Center,undefined
[7] Tarbiat Modares University,undefined
来源：
DARU Journal of Pharmaceutical Sciences | / 25卷
关键词：
Hepatitis C; Sofosbuvir; Ribavirin; Pegylated-interferon; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Pegylated and non-pegylated interferon-alfa and ribavirin for the treatment of mild chronic hepatitis C: A systematic review and meta-analysis
    Hartwell, Debbie
    Shepherd, Jonathan
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 (01) : 56 - 62
  • [22] Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis
    Alavian, Seyed Moayed
    Rezaee-Zavareh, Mohammad Saeid
    HEPATITIS MONTHLY, 2016, 16 (09)
  • [23] TYPE II MIXED CRYOGLOBULINEMIA IN PATIENTS WITH HEPATITIS C VIRUS: TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN
    Malaguarnera, Michele
    Scuderi, Laura
    Ardiri, Annalisa
    Malaguarnera, Giulia
    Bertino, Nicoletta
    Ruggeri, Irene Maria
    Greco, Carmela
    Ozyalcn, Erdogan
    Bertino, Emanuele
    Bertino, Gaetano
    ACTA MEDICA MEDITERRANEA, 2015, 31 (03): : 651 - 662
  • [24] Meta-analysis of the efficacy and safety of sofosbuvir for the treatment of hepatitis C virus infection
    Yang, Hye Jin
    Ryoo, Ju Yeon
    Yoo, Bong Kyu
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (05) : 698 - 708
  • [25] Meta-analysis: amantadine may lower the efficacy of pegylated interferon plus ribavirin in treatment-naive hepatitis C genotype 1 patients
    Chen, Jian
    Shi, Jian
    Xie, Wei-Fen
    Zeng, Xin
    Lin, Yong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (10) : E748 - E752
  • [26] Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients
    Devaki, Pardha
    Jencks, David
    Yee, Brittany E.
    Nguyen, Mindie H.
    HEPATOLOGY INTERNATIONAL, 2015, 9 (03) : 431 - 437
  • [27] Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients
    Pardha Devaki
    David Jencks
    Brittany E. Yee
    Mindie H. Nguyen
    Hepatology International, 2015, 9 : 431 - 437
  • [28] Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C
    Zandieh, Iman
    Adenwalla, Mohamed
    Cheong-Lee, Cindy
    Ma, Patrick E.
    Yoshida, Eric M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (30) : 4908 - 4910
  • [29] Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
    Sundaram, Vinay
    Kowdley, Kris V.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2016, 8 : 75 - 80
  • [30] Analysis of sustained virological response to pegylated interferon & ribavirin treatment in compensated cirrhosis due to hepatitis C virus, genotype 3 infection
    Subhan, Amna
    Jafri, Wasim
    Mumtaz, Khalid
    Hamid, Saeed S.
    Abid, Shahab
    Shah, Hasnain
    Jafri, Nida
    Yakoob, Javed
    Ahmed, Zubair
    GASTROENTEROLOGY, 2008, 134 (04) : A832 - A832
12345